RNA interference and its role in cancer therapy

Advanced Pharmaceutical Bulletin

Volumn 4, Issue 4, 2014, Pages 313-321

  Mansoori, Behzad ^a   Shotorbani, Siamak Sandoghchian ^a   Baradaran, Behzad ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; RNAi; Treatment

Indexed keywords

ALN VSP 02; ALN VSP02; ARGONAUTE PROTEIN; ATU 027; BI SHORT HAIRPIN RNA; CALAA 01; CELL PROTEIN; DICER; DNA DIRECTED RNA POLYMERASE III; EZN 2968; FANG; FANG VACCINE; FURIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KINESIN SPINDLE PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; PIWI INTERACTING RNA; POLO LIKE KINASE 1; PROMOTER ASSOCIATED RNA; RIBONUCLEASE III; RIBONUCLEOTIDE REDUCTASE; RNA POLYMERASE II; SHORT HAIRPIN RNA; SIG12D LODER; SMALL INTERFERING RNA; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; SURVIVIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; X INACTIVATION RNA;

ADENYLATION; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ASTROCYTOMA; CANCER THERAPY; CELL CLONING; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; DURABILITY; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENETIC SIMILARITY; GENETIC VARIABILITY; GENOME; HUMAN; LIVER TUMOR; LYMPHOMA; MELANOMA; METASTASIS INHIBITION; METASTASIS POTENTIAL; NONHUMAN; ONCOGENE; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SOLID TUMOR; TREATMENT DURATION; TUMOR SUPPRESSOR GENE;

EID: 84906273175     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2014.046     Document Type: Review

References (72)

1. Gesteland RF, Cech TR, Atkins JF. The RNA World. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2006.
2. Consortium EP, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447(7146):799-816.
3. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science 2005;309(5740):1559-63.
4. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 2006;38(6):626-35.
5. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005;308(5725):1149-54.
6. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulkner GJ, Brown MK, et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods 2008;5(7):613-9.
7. Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008;322(5909):1845-8.
8. Johnson JM, Edwards S, Shoemaker D, Schadt EE. Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet 2005;21(2):93-102.
9. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007;316(5830):1484-8.
10. Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, et al. Divergent transcription from active promoters. Science 2008;322(5909):1849-51.
11. Levin JZ, Yassour M, Adiconis X, Nusbaum C, Thompson DA, Friedman N, et al. Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nat Methods 2010;7(9):709-15.
12. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391(6669):806-11.
13. Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol 2005;23(2):222-6.
14. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 2005;123(4):607-20.
15. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003;115(2):209-16.
16. Brodersen P, Voinnet O. The diversity of RNA silencing pathways in plants. Trends Genet 2006;22(5):268-80.
17. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009;136(4):642-55.
18. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009;10(2):94-108.
19. Malone CD, Hannon GJ. Small RNAs as guardians of the genome. Cell 2009;136(4):656-68.
20. Dykxhoorn DM, Lieberman J. Knocking down disease with siRNAs. Cell 2006;126(2):231-5.
21. Rao DD, Vorhies JS, Senzer N, Nemunaitis J. siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 2009;61(9):746-59.
22. Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev 2003;67(4):657-85.
23. Matzke MA, Birchler JA. RNAi-mediated pathways in the nucleus. Nat Rev Genet 2005;6(1):24-35.
24. Cullen BR. Induction of stable RNA interference in mammalian cells. Gene Ther 2006;13(6):503-8.
25. Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C, et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 2003;33(3):396-400.
26. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33(3):401-6.
27. Belostotsky D. Exosome complex and pervasive transcription in eukaryotic genomes. Curr Opin Cell Biol 2009;21(3):352-8.
28. Bortoluzzi S, Biasiolo M, Bisognin A. MicroRNA-offset RNAs (moRNAs): by-product spectators or functional players? Trends Mol Med 2011;17(9):473-4.
29. Ender C, Krek A, Friedländer MR, Beitzinger M, Weinmann L, Chen W, et al. A human snoRNA with microRNA-like functions. Mol Cell 2008;32(4):519-28.
30. Gerbi SA. Small nucleolar RNA. Biochem Cell Biol 1995;73(11-12):845-58.
31. Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J 2001;20(14):3617-22.
32. Langenberger D, Bermudez-Santana C, Hertel J, Hoffmann S, Khaitovich P, Stadler PF. Evidence for human microRNA-offset RNAs in small RNA sequencing data. Bioinformatics 2009;25(18):2298-301.
33. Lee JT, Davidow LS, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet 1999;21(4):400-4.
34. Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol 2007;8(3):209-20.
35. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009;10(3):155-9.
36. Ogawa Y, Sun BK, Lee JT. Intersection of the RNA interference and X-inactivation pathways. Science 2008;320(5881):1336-41.
37. Shi W, Hendrix D, Levine M, Haley B. A distinct class of small RNAs arises from pre-miRNA-proximal regions in a simple chordate. Nat Struct Mol Biol 2009;16(2):183-9.
38. Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P, Mattick JS. Small RNAs derived from snoRNAs. RNA 2009;15(7):1233-40.
39. Taft RJ, Kaplan CD, Simons C, Mattick JS. Evolution, biogenesis and function of promoter-associated RNAs. Cell Cycle 2009;8(15):2332-8.
40. Thompson DM, Parker R. Stressing out over tRNA cleavage. Cell 2009;138(2):215-9.
41. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23(13):1494-504.
42. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11(3):228-34.
43. Cullen BR. RNAi the natural way. Nat Genet 2005;37(11):1163-5.
44. Zeng Y, Yi R, Cullen BR. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 2005;24(1):138-48.
45. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425(6956):415-9.
46. Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 2002;21(21):5875-85.
47. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002;21(17):4663-70.
48. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004;117(1):69-81.
49. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003;17(24):3011-6.
50. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001;293(5532):1146-50.
51. Sontheimer EJ, Carthew RW. Molecular biology. Argonaute journeys into the heart of RISC. Science 2004;305 (5689):1409-10.
52. Preall JB, Sontheimer EJ. RNAi: RISC gets loaded. Cell 2005;123(4):543-5.
53. Rand TA, Petersen S, Du F, Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 2005;123(4):621-9.
54. Hutvágner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002;297(5589):2056-60.
55. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004;304(5670):594-6.
56. Humphreys DT, Westman BJ, Martin DI, Preiss T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 2005;102(47):16961-6.
57. Thermann R, Hentze MW. Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature 2007;447(7146):875-8.
58. Judge AD, Robbins M, Tavakoli I, Levi J, Hu L, Fronda A, et al. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J Clin Invest 2009;119(3):661-73.
59. Parker R, Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007;25(5):635-46.
60. Yazdi Samadi B, Valizadeh M. Genetics A molecular approach. Iran: Tehran Univercity Publishers; 1388.
61. Fire AZ. Gene silencing by double-stranded RNA. Cell Death Differ 2007;14(12):1998-2012.
62. Bora RS, Gupta D, Mukkur TK, Saini KS. RNA interference therapeutics for cancer: challenges and opportunities (review). Mol Med Rep 2012;6(1):9-15.
63. Tao W, South VJ, Zhang Y, Davide JP, Farrell L, Kohl NE, et al. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer cell 2005;8(1):49-59.
64. Leenders F, Mopert K, Schmiedeknecht A, Santel A, Czauderna F, Aleku M, et al. PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase. EMBO J 2004;23(16):3303-13.
65. Santel A, Aleku M, Roder N, Mopert K, Durieux B, Janke O, et al. Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models. Clin Cancer Res 2010;16(22):5469-80.
66. Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol 2012;19(1):60-71.
67. Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J 2011;6(9):1130-46.
68. Rao DD, Wang Z, Senzer N, Nemunaitis J. RNA interference and personalized cancer therapy. Discov Med 2013;15(81):101-10.
69. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010;464(7291):1067-70.
70. Paninski L. Estimation of entropy and mutual information. Neural Comput 2003;15(6):1191-253.
71. Duxbury MS, Whang EE. RNA interference: a practical approach. J Surg Res 2004;117(2):339-44.
72. Kerbel RS. A cancer therapy resistant to resistance. Nature 1997;390(6658):335-6.